GlaxoSmithKline Intellectual Property Development Ltd
发明人:
申请号：
EP18833307.4
公开号：
EP3724164A1
申请日:
2018.12.05
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
Provided are IDO1 inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases. Formula I Wherein R1 is a group having Formula II
